Instructions For Author
These Instructions for Authors describe how to prepare and submit manuscripts to Radiation and Nuclear Medicine. JRNM publishes peer reviewed, open access work across imaging, therapy, radiation physics, radiopharmaceutical science, and clinical translation. Clear adherence to these guidelines supports a smooth review process and timely publication.
Please review each section carefully before submission. Manuscripts that follow these requirements receive faster editorial decisions and require fewer revisions.
Scope and Article Types
What JRNM publishes
JRNM welcomes original research, clinical studies, systematic reviews, meta analyses, technical notes, and interdisciplinary methods papers. Manuscripts should focus on diagnostic or therapeutic nuclear medicine, radiation oncology integration, imaging physics, radiochemistry, or radiation safety practice.
We encourage studies that connect imaging findings to clinical outcomes, optimize dosimetry, improve radiotracer synthesis, or advance regulatory and safety frameworks. Use language that is accessible to clinicians and physicists alike.
Submission Checklist
Title Page
Full author details, affiliations, and corresponding author contact
Abstract
Structured summary, objectives, methods, results, conclusions
Methods
Reproducible protocols, dosimetry, and instrumentation details
Data
Availability statement, repository links, and access notes
Formatting and Structure
Manuscript organization
Use standard scientific structure: Title, Abstract, Introduction, Methods, Results, Discussion, Conclusion, and References. Provide three to six keywords and a short running title. Define abbreviations at first use and report units consistently, especially for radiation dose metrics.
Figures must be high resolution and labeled clearly. Tables should be editable and include captions that explain all abbreviations and units. For imaging studies, include acquisition parameters and reconstruction methods to support reproducibility.
For clinical studies, report inclusion criteria, ethical approvals, and safety monitoring protocols. If the study involves radiopharmaceutical administration, include activity dosing, biodistribution, and adverse event reporting where applicable.
Submission Workflow
Prepare
- Confirm scope alignment and article type
- Verify authorship order and contributions
- Collect ethics approvals and consent forms
- Ensure figures and tables meet quality standards
Submit
- Upload manuscript, figures, and supplements
- Provide data availability and funding statements
- Suggest reviewers with relevant expertise
- Include cover letter with novelty summary
Revise
- Address reviewer feedback point by point
- Highlight changes in the manuscript
- Provide a detailed response letter
- Confirm updated data and ethics statements
Ethics and Transparency
Ethics and Consent: Human and animal studies must include ethics approval details, consent statements, and safety protocols. Follow CONSORT, STROBE, PRISMA, or ARRIVE when applicable.
Authorship: All authors must contribute substantially, approve the final manuscript, and accept responsibility for the work. Changes after submission require written approval.
Conflicts and Funding: Disclose financial relationships, sponsor roles, and grant identifiers. If unfunded, state this clearly in acknowledgments.
Data and Code: Provide repository links, access conditions, and licensing terms. Include code versioning and dependencies for computational studies.
References and Citations
Accuracy and traceability
Use a consistent citation style and include DOIs when available. Cite datasets, software, and preprints with persistent identifiers. Reference accuracy is the responsibility of the authors and will be checked during production.
For imaging datasets or clinical trial registrations, include registry identifiers. Ensure that citations support the scientific context and include recent literature in radiation and nuclear medicine.
Preprints and Prior Dissemination
Transparency for prior sharing
JRNM accepts submissions previously posted as preprints, provided they are disclosed at submission. Authors should update the preprint record after publication to link to the final article. Prior conference abstracts are acceptable if the manuscript is substantially expanded.
After Acceptance
Production, licensing, and publication
After acceptance, the editorial office issues an APC invoice and begins production once payment is confirmed. Authors receive proofs for final review and must verify author details, dosage values, and figure accuracy. Only minor corrections are permitted during proofing.
Articles are published under an open license to maximize reuse and citation. JRNM supports repository deposits and metadata distribution to indexing platforms to improve discoverability.
Author Support
Corresponding author and cover letter guidance
Provide a corresponding author with full contact information for editorial communication. Include ORCID identifiers when available to improve attribution. A clear cover letter should summarize novelty, clinical relevance, and scope alignment. If the work is linked to a special issue, state the issue name explicitly.
Use descriptive section headings and consistent numbering. For imaging or dosimetry studies, consider adding a short highlights section that summarizes key findings for rapid scanning by clinicians and physicists.
Submit your manuscript to JRNM
Select ManuscriptZone for full workflow or use our simplified submission form.
Reporting Guidelines
Standards for transparent research
Use reporting guidelines appropriate to study design. CONSORT applies to randomized trials, STROBE to observational studies, PRISMA to systematic reviews, and ARRIVE to animal research. For diagnostic accuracy studies, follow STARD or similar imaging standards when applicable.
Figures and Imaging Data
Presentation quality expectations
Imaging figures should include acquisition parameters, reconstruction methods, and relevant quantitative values. Provide scale bars, dose units, and clear legends. Tables should be editable and include definitions for all abbreviations.
Clinical Trials
Registration and safety reporting
Clinical trials should include registration numbers and protocol identifiers. Report radiation dose limits, safety monitoring, and any deviations from protocol. Include a clear description of study population and inclusion criteria.
Data and Code
Reproducibility expectations
Provide repository links for datasets and code with version details. If clinical data cannot be shared, explain restrictions and provide controlled access pathways. A short data dictionary improves reuse.
Appeals and Corrections
Maintaining the scholarly record
Authors may appeal decisions by providing a detailed response to reviewer comments. Appeals are reviewed by senior editors and may involve additional expert evaluation. Post publication corrections are issued when necessary to maintain record accuracy.
Keywords and Abstracts
Discoverability best practices
Provide three to six keywords that reflect imaging modality, radionuclide, and clinical context. Structured abstracts should summarize objectives, methods, results, and conclusions with clear quantitative outcomes.
Supplementary Material
Supporting files
Supplementary files should be clearly labeled and referenced in the main text. Include protocol details, extended tables, or imaging datasets that support reproducibility and interpretation.
Funding Statements
Transparency in support
List all funding sources and grant numbers, and describe the role of sponsors. If no external funding was received, state this explicitly.
Manuscript Length and Style
Clarity for multidisciplinary readers
Use concise scientific language and avoid unnecessary jargon. Prioritize clear methods and results over extended background. Use headings and consistent numbering to help reviewers navigate complex content.
Proof Review
Final quality checks
Proofs are the final opportunity to verify author details, dose values, and figure accuracy. Only minor corrections are permitted at this stage to maintain production timelines.
Authorship Changes
Transparent updates
Requests to add or remove authors after submission require written approval from all contributors and justification to the editorial office.
Data Sharing Exceptions
Responsible limitations
If data cannot be shared due to privacy or regulatory constraints, explain the limitation and provide a controlled access pathway when possible. Reviewers should still be able to evaluate study validity.
Units and Nomenclature
Consistency in reporting
Use standardized units for activity and dose, and define all abbreviations. Consistent nomenclature improves clarity for multidisciplinary readers and reduces revision requests.
Submission Files
Ensure completeness
Upload the manuscript, figures, tables, supplementary files, and cover letter as separate files. Clear file naming reduces processing time and helps reviewers locate supporting materials.
Corresponding Author
Primary contact
Provide a single corresponding author with institutional email, full address, and phone number. This ensures efficient communication during review and production.
Checklist Reminder
Final review
Before submission, confirm that all figures open correctly, legends match the text, and dose values are consistent across tables and results.
Production Timeline
Post acceptance
Timely proof review helps maintain publication schedules. Delays can slow indexing and discovery for clinical audiences.
Author Identifiers
ORCID and IDs
Include ORCID identifiers for all authors when available. Consistent identifiers improve attribution, indexing accuracy, and researcher visibility across clinical and technical databases.
Plain Language
Improve accessibility
Consider a brief plain language summary for complex protocols to help multidisciplinary readers understand clinical significance.
Data Availability Reminder
Transparency note
Ensure that data availability statements are complete and consistent across the manuscript, supplementary files, and repository records.
Final Note
Consistency check
Ensure that figures, tables, and text describe the same dose values, imaging parameters, and statistical results throughout the manuscript.
Author Checklist
Final confirmation
Confirm that ethical approvals, data statements, and funding disclosures are included before submission.
Final Check
Submission readiness
Verify that all required forms and disclosures are complete before uploading.